393 articles with AmerisourceBergen
Revenues of $43.3 billion for the Second Quarter, a 5.6 Percent Increase Year-Over-Year
Lash Group and Medisafe Form Strategic Collaboration to Advance Patient Adherence by Deploying Mobile Engagement Before the First Fill
Together they will provide an end-to-end patient adherence solution that combines a top-rated mobile platform within Lash Group’s current hub services programs.
US Bioservices Selected by Janssen as Single-Source Specialty Pharmacy Provider for BALVERSA™ (erdafitinib)
US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, today announced that it has been selected by Janssen Biotech, Inc. (Janssen) to dispense BALVERSA™ (erdafitinib). Janssen received U.S. Food and Drug Administration (FDA) approval for BALVERSA™ on April 12, 2019
AmerisourceBergen Foundation Commemorates National Prescription Drug Take Back Day with Grant to CADCA in Support of Youth-Led Drug Disposal Program
Grant will empower next generation of youth advocates and equip them to make change
DIACOMIT® is approved by the FDA in two formulations – capsules and powder for oral suspension.
AmerisourceBergen, a global healthcare solutions leader, in concert with their industry trade association the Healthcare Distribution Alliance, has proposed a comprehensive framework that would support the proposed move from the current rebate system to point-of-sale (POS) discounts in response to the Department of Health and Human Services’ (HHS) Notice of Proposed Rule Making regarding the Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals.
The AmerisourceBergen Foundatio has committed $25,000 to support relief efforts in communities affected by the tornadoes that recently swept through the Southeast United States.
Lash Group to Amplify Patient Engagement Capabilities with AllazoHealth Artificial Intelligence and Predictive Analytics Tool
Partnership will enhance patient adherence and engagement programs through targeted and personalized recommendations that will empower at-risk patients to ultimately make healthier choices.
The Board of Directors of AmerisourceBergen Corporation declared a quarterly cash dividend of $0.40 per common share, payable March 4, 2019, to stockholders of record at the close of business on February 19, 2019.
Revenues of $45.4 Billion for the First Quarter, a 12.2 Percent Increase Year-Over-Year
Today, AmerisourceBergen, a global healthcare solutions leader, announced the appointment of Silvana Battaglia to its executive team as Executive Vice President and Chief Human Resources Officer.
Safe Rx today announced its product availability in AmerisourceBergen, with merchandising kits available to all AmerisourceBergen California customers.
AmerisourceBergen Corporation today announced that it plans to release its results for the First Quarter Fiscal 2019 on Thursday, January 31, 2019, prior to the opening of trading on the New York Stock Exchange.
Michigan Healthcare Professionals Joins ION Solutions GPO Network & Selects Oncology Supply as Exclusive Specialty Distributor
AmerisourceBergen, a global healthcare solutions leader, today announced that Michigan Healthcare Professionals (MHP) has selected ION Solutions for GPO contracting and Oncology Supply for exclusive specialty distribution.
AmerisourceBergen's Pharmacy Check-Up Survey and Ambulatory Outlook for Health System Pharmacies Report Find Opportunities for Health System Pharmacists to Play a Greater Role in Healthcare
Nearly 80 percent of hospital pharmacists look forward to a greater role in healthcare and are well positioned to take on an expanded role, according to new research sponsored by AmerisourceBergen.
US Bioservices Selected by Bayer and Its Collaboration Partner Loxo Oncology, Inc. to Dispense Vitrakvi® (larotrectinib)
New therapy approved to treat gene fusions across several different types of tumors
Investments will enhance customer experience and specialty transportation services through advanced technology solutions
AmerisourceBergen Foundation Donates Nearly 1 Million Drug Deactivation Resources and Provides Funding to 20+ Organizations to Help Combat the Opioid Epidemic
AmerisourceBergen has also distributed nearly one million drug deactivation resources through its Safe Disposal Support Program to 44 states and 140 organizations across the U.S.
UK-based subsidiaries Centaur Services, St Francis Group, Vetswest and Vet Space now part of MWI Animal Health offering
Revenues of $43.3 Billion for the Fourth Quarter, a 10.7 Percent Increase Year-Over-Year